Global assembling of Academicians, Researchers, Scholars & Industry to disseminate and exchange information at 100+ Allied Academics Conferences

Arthur P. Bollon
Arthur P. Bollon
Co-Founder and Director
SignPath Pharma
USA
Biography

Presently: Director, Co-Founder of SignPath Pharma, developing Curcumin for treatment of cancer. Founder, Chairman & CEO of VITRUVIAN BioMedical, Inc. which is developing an Alzheimer Disease Blood Test and Therapeutic Vaccine. First company founded was Wadley Biosciences/LPL which was a joint venture between Wadley Institutes and Phillips Petroleum with focus on cancer and infectious disease, 1987-1992. The second company founded was Cytoclonal Pharmaceutics, which went public with an IPO in 1995, and entered into a licensing agreement with Bristol Myers on Taxol production, and was merged to create OPKO Health. Former Chairman & CEO of HemoBioTech, Inc., developing HemoTech as viable substitute for human red blood cells.

Research Interest

Neurology, Neuro-degenerative diseases

Allied Academies Global Conference Directory

Mail us at

Drop us a mail for program enquiry
neuroinfection@alliedmeetings.com
Sponser/Exhibiting/advertising
neuroimmunology@alliedmeetings.com
General queries
neuroimmunologyallied@gmail.com
More details about sponsorship:sponsors@alliedacademies.com
Copyright © 2017-2018 Allied Academies, All Rights Reserved.